Alkermes Awarded 2022 Platinum Bell Seal for Workplace Mental Health

·1 min read

Northampton, MA --News Direct-- Alkermes

We’re proud to announce that we’ve received the 2022 Bell Seal for Workplace Mental Health at Platinum from Mental Health America! This recognition demonstrates our firm commitment to fostering a mentally healthy workplace for all our employees. Learn more: https://bit.ly/3kLe6oQ

About AlkermesAlkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com

View source version on newsdirect.com: https://newsdirect.com/news/alkermes-awarded-2022-platinum-bell-seal-for-workplace-mental-health-275435594

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting